Table 4.
Differences in time and distance travelled to primary treatment for men with prostate cancer in inner and outer regional/remote areas of Tasmania.
| Time in days, median (IQR) | Additional time for individuals living in outer regional/remote areas | ||
|---|---|---|---|
| Unadjusted PR (95% CI) |
Adjusted* PR (95% CI) |
||
| Time to primary treatment (days) | |||
| Inner regional | 61 (31–101) | n.a | n.a |
| Outer regional/remote | 69 (36–116) | 9.51 (2.35–16.68) | 11.02 (3.92–18.12) |
| % of total dataset, % (n†) | 80.1% (1222) | ||
| Time to primary active treatment (days) | |||
| Inner regional | 75 (49–115) | n.a | n.a |
| Outer regional/remote | 82 (50–131) | 6.66 (− 1.05–14.38) | 9.25 (1.72–16.79) |
| % of total dataset, % (n†) | 60.1% (917) | ||
| Low-risk | |||
| Inner regional | 93 (63–123) | n.a | n.a |
| Outer regional/remote | 96 (68–185) | 12.98 (− 19.05–45.01) | 16.21 (− 14.47–46.89) |
| % of Total dataset, % (n†) | 4.6% (70) | ||
| Intermediate-risk | |||
| Inner regional | 85 (61–126) | n.a | n.a |
| Outer regional/remote | 95 (63–133) | 5.16 (− 4.17–14.49) | 5.61 (− 3.72–14.93) |
| % of Total dataset, % (n†) | 28.6% (437) | ||
| High-risk | |||
| Inner regional | 64 (42–100) | n.a | n.a |
| Outer regional/remote | 75 (43–136) | 13.14 (− 1.66–27.93) | 14.58 (− 0.50–29.65) |
| % of Total dataset, % (n†) | 17.4% (265) | ||
| Very high-risk/metastatic | |||
| Inner regional | 36 (16–59) | n.a | n.a |
| Outer regional/remote | 49 (23–72) | 2.78 (− 12.58–18.12) | 2.97 (− 12.47–18.40) |
| % of Total dataset, % (n†) | 8.1% (123) | ||
IQR = Interquartile Range; PR = Prevalence Ratio; CI = Confidence Interval; n.a. = Not Applicable.
*Adjusted for age at diagnosis.
†All analyses are weighted for remoteness classification (see “Methods”). Subject numbers are rounded to the nearest integer value.